Features of the Prevention of Absorbent Salt Formation of Internal and External Drainages During Prolonged Drainage of the Upper Urinary Tract
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: to evaluate the effectiveness of the phytotherapeutic drug Canephron® N in the prevention of absorbent salt formation of internal and external drains with prolonged drainage of the upper urinary tract.
Materials and methods. The study included 76 patients aged 16 to 65 years with drainage of the kidneys due to obstructive uropathy. Depending on the chosen treatment tactics, patients were divided into two groups. The main group (n = 49) in combination with standard care for stents received a phytopreparation Canephron® N 2 tablets three times a day. Patients in the control group (n = 27) received only standard stent care. The sizes of the renal cavities were evaluated using a furosemide test, the reaction to a urine nitrite test, the presence of bacteriuria and the frequency of salt incrustation of stents and drains.
Results. The quality of the functioning of drainage systems in the main group was significantly higher than that of the control group. The test with furosemide showed a smaller size of the kidney bowls in the main group by 24.3% than in patients of the control group with external drainage and 17% less with internal drainage. Positive indicators of the nitrite test in the group of patients who used the Canephron® N phytopreparation in complex therapy were lower by 54% and 53%, respectively, in the subgroups of external and internal drainage compared to the control group. Some patients with saline occlusion of the drainage systems accounted for 16% in the main group versus 85% in the control group.
Conclusion. The use of Canephron® N in patients with drainage of the upper urinary tract can prevent the development of salt incrustation of stents, improve the quality of drainage, and also prevent the development of microbial inflammatory processes in the urinary tract.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Пасєчніков СП, Сайдакова НО, Глєбов АС. Сучасний стан проблеми інфекції нирок та сечовивідних шляхів в Україні. Урологія. 2010;14:72–4.
Черненко ДВ, Черненко ВВ, Клюс АЛ, Шило ВН. Шляхи покращення довготривалої функції дренажів при зовнішньому та внутрішньому дренуванні нирок у хворих з обструктивними нефропатіями. Здоров’я чоловіка. 2012;2:72–6.
Zahran MH, Harraz AM, Taha DE, El-Nahas AR, Elshal A, Shokeir AA. Studing the morbidity and renal function outcome of missed internal ureteral stents: A matched pair analysis. J. Endourol. 2015;29:1070–5. doi: 10.1089/end.2015.0047
Lin TF, Lin WR, Chen M, Yang TY, Hsu JM, Chiu AW. The risk factors and complications of forgotten double-J stents: A single center experience. Journal of the Chinese Medical Association. 2019 July 22;82(10):1. doі: 10.1097/JCMA.0000000000000161.
Naber K, Bergman B, Bishop M, Grabe M et al. Guidelines on Urinary and Male Genital Tract Infections. European Association of Urology. 2013;30.
Perepanova TS, Golovanov SA, Merinov DS, Arustamov LD, Radzhabov UA. Metaphylaxis of infectious kidney stones after percutaneous nephrolithotripsy. Experimental and clinical urology. 2016;4:96–9.
Riedl CR, Plas E, Hubner WA, Zimmerl H, Ulrich W, Pfluger H. Bacterial colonization of ureteral stents. Eur Urol. 1999;36(1):53–9. doi:10.1159/000019927.
Возіанов СО, Коваль ДВ, Шило ВМ. Ефективність сучасної емпіричної антибактеріальної терапії інфекції сечовивідних шляхів. Здоров’я чоловіка. 2013;3 (46);151–2.
